Shinpoong Pharmaceutical Co.,Ltd (KRX:019170)
South Korea · Delayed Price · Currency is KRW
10,470
+220 (2.15%)
At close: Apr 8, 2026
Revenue by Segment
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
Pharmaceutical Manufacturing and Sales | | | 200.23B | 209.29B | 189.24B | 197.75B | 189.72B | | | |
Pharmaceutical Manufacturing and Sales Growth | | | -4.33% | 10.60% | -4.31% | 4.23% | - | | | |
| | | 200.23B | 209.29B | 189.24B | 197.75B | 189.72B | | | |
| | | -4.33% | 10.60% | -4.31% | 4.23% | - | | | |
Revenue by Geography
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
| | | 160.32B | 196.17B | 179.78B | 187.33B | 180.10B | | | |
| | | -18.28% | 9.11% | -4.03% | 4.02% | - | | | |
| | | 13.93B | - | - | - | - | | | |
| | | 1.29B | - | - | - | - | | | |
| | | 1.82B | - | - | - | - | | | |
| | | 12.89B | - | - | - | - | | | |
| | | 9.99B | - | - | - | - | | | |
| | | - | 16.62B | 9.45B | 10.42B | 9.63B | | | |
| | | - | 75.78% | -9.31% | 8.29% | - | | | |
| | | - | -3.50B | - | - | - | | | |
| | | 200.23B | 209.29B | 189.24B | 197.75B | 189.72B | | | |
| | | -4.33% | 10.60% | -4.31% | 4.23% | - | | | |
Source: S&P Global Market Intelligence.